Effects of electroconvulsive therapy on cerebral A

A1 adenosine receptor electroconvulsive therapy major depressive disorder positron emission tomography seizure quality

Journal

Frontiers in psychiatry
ISSN: 1664-0640
Titre abrégé: Front Psychiatry
Pays: Switzerland
ID NLM: 101545006

Informations de publication

Date de publication:
2023
Historique:
received: 24 05 2023
accepted: 27 06 2023
medline: 31 7 2023
pubmed: 31 7 2023
entrez: 31 7 2023
Statut: epublish

Résumé

Sleep deprivation and electroconvulsive therapy (ECT) effectively ameliorate symptoms in major depressive disorder (MDD). In rodents, both are associated with an enhancement of cerebral adenosine levels, which in turn likely influence adenosinergic receptor expression. The aim of the current study was to investigate cerebral A Regional A ECT had a strong antidepressive effect ( In the present study, therapeutically effective ECT treatment did not result in coherent changes of A

Identifiants

pubmed: 37520217
doi: 10.3389/fpsyt.2023.1228438
pmc: PMC10380952
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1228438

Informations de copyright

Copyright © 2023 Kroll, Grözinger, Matusch, Elmenhorst, Novakovic, Schneider and Bauer.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Eur J Neurosci. 2003 Aug;18(4):820-8
pubmed: 12925008
Neurosci Lett. 1993 Nov 26;163(1):11-4
pubmed: 8295723
Brain Stimul. 2019 May - Jun;12(3):714-723
pubmed: 30635228
Neurochem Int. 2001 Feb;38(2):107-25
pubmed: 11137880
Neuropharmacology. 2018 Dec;143:106-112
pubmed: 30253174
Mol Psychiatry. 2022 Apr;27(4):2273-2281
pubmed: 35165397
Nat Med. 2001 May;7(5):541-7
pubmed: 11329053
Transl Psychiatry. 2013 Jan 15;3:e212
pubmed: 23321809
Proc Natl Acad Sci U S A. 2018 Jul 31;115(31):8009-8014
pubmed: 30012607
Ann Neurol. 1992 Nov;32(5):618-24
pubmed: 1449242
Purinergic Signal. 2011 Dec;7(4):447-52
pubmed: 21695518
Neuroimage. 2005 Feb 15;24(4):1192-204
pubmed: 15670697
Neuroscience. 1987 Sep;22(3):813-26
pubmed: 2825070
Neurosci Lett. 2004 Jan 23;355(1-2):21-4
pubmed: 14729225
ACS Chem Neurosci. 2017 May 17;8(5):955-960
pubmed: 28287253
Sleep Med Rev. 2002 Oct;6(5):361-77
pubmed: 12531127
Brain Res. 1984 Jan 16;291(1):188-92
pubmed: 6320953
Eur J Nucl Med Mol Imaging. 2007 Jul;34(7):1061-70
pubmed: 17242921
Eur Arch Psychiatry Clin Neurosci. 2018 Dec;268(8):831-838
pubmed: 30022318
Physiol Behav. 2013 Jan 17;109:1-7
pubmed: 23159724
World J Biol Psychiatry. 2013 Aug;14(6):432-40
pubmed: 22409536
J Neurochem. 1989 Feb;52(2):641-6
pubmed: 2911034
J Affect Disord. 2018 Feb;227:627-632
pubmed: 29172056
J Med Chem. 2002 Nov 7;45(23):5150-6
pubmed: 12408725
Mol Imaging Biol. 2018 Apr;20(2):284-291
pubmed: 28895043
Neuroreport. 1999 Nov 26;10(17):3535-41
pubmed: 10619640
Cell Tissue Res. 2019 Jul;377(1):5-20
pubmed: 30560458
Acta Psychiatr Scand Suppl. 1960;35(145):49-67
pubmed: 14409401
Eur Arch Psychiatry Clin Neurosci. 2018 Dec;268(8):819-830
pubmed: 29876649
Mol Imaging Biol. 2014 Oct;16(5):699-709
pubmed: 24595700
Acta Psychiatr Scand. 2021 Jan;143(1):22-35
pubmed: 33145770
J ECT. 2016 Jun;32(2):88-92
pubmed: 26397151
Wien Klin Wochenschr. 2015 Apr;127(7-8):297-302
pubmed: 25732919
Neuroscience. 1987 Sep;22(3):827-39
pubmed: 2825071
Epilepsia. 2014 Feb;55(2):233-44
pubmed: 24483230
Neuron. 2003 Apr 24;38(2):157-60
pubmed: 12718851
Acta Psychiatr Scand. 2020 Apr;141(4):304-315
pubmed: 31774547
J Cereb Blood Flow Metab. 2013 Sep;33(9):1394-401
pubmed: 23695433
Neuroimage. 2003 Aug;19(4):1760-9
pubmed: 12948730
Brain Res. 1996 Feb 26;710(1-2):56-68
pubmed: 8963679
J Clin Invest. 2019 Jan 2;129(1):364-372
pubmed: 30530989
Brain Stimul. 2020 Mar - Apr;13(2):450-456
pubmed: 31889671
J Nucl Med. 2012 Nov;53(11):1723-9
pubmed: 22966134
Eur J Nucl Med Mol Imaging. 2012 Jun;39(6):990-1000
pubmed: 22441582
Proc Natl Acad Sci U S A. 2017 Apr 18;114(16):4243-4248
pubmed: 28373571
Trends Pharmacol Sci. 2002 May;23(5):238-45
pubmed: 12008002
Physiol Rev. 2018 Jul 1;98(3):1591-1625
pubmed: 29848236
Glia. 2007 Jan 1;55(1):36-45
pubmed: 17004232
Front Cell Neurosci. 2013 Jul 16;7:109
pubmed: 23882181
Sleep Med Rev. 2011 Apr;15(2):123-35
pubmed: 20970361
Handb Exp Pharmacol. 2009;(193):471-534
pubmed: 19639292
Neuron. 2015 Aug 5;87(3):549-62
pubmed: 26247862
Int J Mol Sci. 2014 Jan 28;15(2):2024-52
pubmed: 24477263
Neurosci Lett. 2000 Apr 21;284(1-2):49-52
pubmed: 10771159
Biochem Pharmacol. 2004 Feb 1;67(3):421-6
pubmed: 15037194
J Neurosci. 2007 Feb 28;27(9):2410-5
pubmed: 17329439
Brain Res Bull. 2019 Sep;151:46-54
pubmed: 30468847
Neurochem Res. 2005 Oct;30(10):1205-17
pubmed: 16341582
Biol Mood Anxiety Disord. 2012 Aug 17;2:14
pubmed: 22901565

Auteurs

Tina Kroll (T)

Institute of Neuroscience and Medicine (INM-2), Forschungszentrum Jülich GmbH, Jülich, Germany.

Michael Grözinger (M)

Department of Psychiatry, Psychotherapy and Psychosomatics, Medical Faculty, RWTH Aachen, Aachen, Germany.

Andreas Matusch (A)

Institute of Neuroscience and Medicine (INM-2), Forschungszentrum Jülich GmbH, Jülich, Germany.

David Elmenhorst (D)

Institute of Neuroscience and Medicine (INM-2), Forschungszentrum Jülich GmbH, Jülich, Germany.
Multimodal Neuroimaging Group, Department of Nuclear Medicine, University Hospital Cologne, Cologne, Germany.

Ana Novakovic (A)

Department of Psychiatry, Psychotherapy and Psychosomatics, Medical Faculty, RWTH Aachen, Aachen, Germany.

Frank Schneider (F)

University Hospital, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.

Andreas Bauer (A)

Institute of Neuroscience and Medicine (INM-2), Forschungszentrum Jülich GmbH, Jülich, Germany.

Classifications MeSH